Moderna, Inc. (MRNA)
215.30
+7.33
(+3.52%)
USD |
NASDAQ |
Oct 28, 10:10
Moderna Market Cap : 85.90B for Oct. 28, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 27, 2026 | 82.98B |
| October 26, 2026 | 79.34B |
| October 23, 2026 | 79.84B |
| October 22, 2026 | 80.85B |
| October 21, 2026 | 98.08B |
| October 20, 2026 | 96.59B |
| October 19, 2026 | 90.53B |
| October 16, 2026 | 86.99B |
| October 15, 2026 | 94.36B |
| October 14, 2026 | 90.29B |
| October 13, 2026 | 86.28B |
| October 12, 2026 | 85.28B |
| October 09, 2026 | 89.78B |
| October 08, 2026 | 78.60B |
| October 07, 2026 | 78.40B |
| October 06, 2026 | 74.80B |
| October 05, 2026 | 81.08B |
| October 02, 2026 | 75.81B |
| October 01, 2026 | 75.39B |
| September 30, 2026 | 76.84B |
| September 29, 2026 | 81.18B |
| September 28, 2026 | 78.71B |
| September 25, 2026 | 79.35B |
| September 24, 2026 | 77.73B |
| September 23, 2026 | 72.66B |
| Date | Value |
|---|---|
| September 22, 2026 | 72.84B |
| September 21, 2026 | 69.00B |
| September 18, 2026 | 61.46B |
| September 17, 2026 | 63.07B |
| September 16, 2026 | 58.10B |
| September 15, 2026 | 57.36B |
| September 14, 2026 | 58.53B |
| September 11, 2026 | 57.44B |
| September 10, 2026 | 54.51B |
| September 09, 2026 | 54.11B |
| September 08, 2026 | 55.99B |
| September 04, 2026 | 58.07B |
| September 03, 2026 | 59.40B |
| September 02, 2026 | 60.17B |
| September 01, 2026 | 61.55B |
| August 31, 2026 | 56.00B |
| August 28, 2026 | 55.06B |
| August 27, 2026 | 56.97B |
| August 26, 2026 | 59.71B |
| August 25, 2026 | 63.37B |
| August 24, 2026 | 55.42B |
| August 21, 2026 | 57.91B |
| August 20, 2026 | 53.19B |
| August 19, 2026 | 69.58B |
| August 18, 2026 | 25.12B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Revolution Medicines, Inc. | 39.69B |
| Vaxcyte, Inc. | 8.761B |
| Twist Bioscience Corp. | 10.93B |
| BioNTech SE | 22.00B |
| Vir Biotechnology, Inc. | 2.003B |
Market Cap Related Metrics
| PS Ratio | 38.05 |
| PEG Ratio | -4.347 |
| Price to Book Value | 12.71 |
| Price | 215.30 |
| Earnings Yield | -3.71% |
| PEGY Ratio | -4.347 |